CK0801 for Treatment of Aplastic Anemia
NCT07499102
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Aplastic Anemia
Interventions
DRUG:
CK0801
Sponsor
Cellenkos, Inc.